Comparing Bendamustine vs Treanda
Bendamustine | Treanda (bendamustine) |
|
---|
Bendamustine | Treanda (bendamustine) |
|
---|---|---|
Prescription only
Prescribed for Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma. Bendamustine may also be used for purposes not listed in this medication guide. |
Prescription only
Treanda is a cytotoxic agent that must be administered by a health professional and may be used to treat chronic lymphocytic leukemia (CLL) and a certain type of non-Hodgkin lymphoma. It can cause... View more |
Related suggestions Non-Hodgkin's Lymphoma
Popular comparisons
|
More about Bendamustine | More about Treanda (bendamustine) | |
Ratings & Reviews | ||
Bendamustine has an average rating of 9.4 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Treanda has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Bendamustine side effects |
View all Treanda side effects |
|
Drug Class | ||
Generic Availability | ||
Lower cost generic |
||
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
|
|
|
Brand Names | ||
Belrapzo, Bendeka, Treanda, Vivimusta | Other bendamustine brands include: Belrapzo, Bendeka, Vivimusta | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
N/A |
N/A |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 298 drugs are known to interact with Bendamustine:
|
A total of 298 drugs are known to interact with Treanda:
|
|
Alcohol/Food/Lifestyle Interactions | ||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | ||
First Approval Date | ||
March 20, 2008 |
October 31, 2008 |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
Professional Resources | ||
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Gazyva
Gazyva is used to treat chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL) in adults ...
Treanda
Treanda (bendamustine) is used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.